H|T: The Healthtech Times – Neuralink implants in first human test subject
Plus: How 23andMe’s valuation fell from $6 billion to nearly $0.
Source: betakit.com
Stay updated with breaking news from Peter Santosham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Plus: How 23andMe’s valuation fell from $6 billion to nearly $0.
Three and half years since its launch, UCeed has grown into six funds and one of Canada’s most active early-stage investors.